| Literature DB >> 29717266 |
Elizabeth E Halvorson1, Timothy R Peters2, Joseph A Skelton3,4, Cynthia Suerken5, Beverly M Snively5, Katherine A Poehling3.
Abstract
BACKGROUND/Entities:
Mesh:
Year: 2018 PMID: 29717266 PMCID: PMC6110981 DOI: 10.1038/s41366-018-0044-y
Source DB: PubMed Journal: Int J Obes (Lond) ISSN: 0307-0565 Impact factor: 5.095
Counts and percentages of the study population by weight category
| All | Normal Weight | Over-weight | Obese | Overall | |
|---|---|---|---|---|---|
| <0.0001 | |||||
| 230 (31) | 158 (38) | 36 (23) | 36 (21) | ||
| 204 (27) | 123 (29) | 33 (21) | 48 (28) | ||
| 159 (21) | 70 (17) | 40 (25) | 49 (28) | ||
| 156 (21) | 69 (16) | 48 (31) | 39 (23) | ||
| 0.91 | |||||
| 185 (25) | 102 (24) | 38 (24) | 45 (26) | ||
| 218 (29) | 118 (28) | 46 (29) | 54 (31) | ||
| 214 (29) | 127 (30) | 45 (29) | 42 (24) | ||
| 132 (18) | 73 (17) | 28 (18) | 31 (18) | ||
| 404 (54) | 213 (51) | 91 (58) | 100 (58) | 0.14 | |
| 0.64 | |||||
| 250 (33) | 142 (34) | 57 (36) | 51 (30) | ||
| 399 (53) | 223 (53) | 77 (49) | 99 (58) | ||
| 100 (13) | 55 (13) | 23 (15) | 22 (13) | ||
| 157 (21) | 93 (22) | 29 (18) | 35 (20) | 0.61 | |
| 0.91 | |||||
| 246 (33) | 137 (33) | 50 (32) | 59 (34) | ||
| 63 (8.6) | 36 (8.6) | 11 (7.0) | 16 (9.3) | ||
| 440 (59) | 247 (59) | 96 (61) | 97 (56) | ||
| 134 (18) | 80 (19) | 26 (17) | 28 (16) | 0.65 | |
| 527 (70) | 308 (73) | 108 (69) | 111 (65) | 0.09 | |
P values are for comparison of characteristics across body weight groups (normal weight, overweight, and 3 obese) based on a chi-squared test.
Individuals with unknown insurance status are included with those who have no private insurance.
Other high risk conditions: chronic cardiac or pulmonary diseases (excluding asthma), diabetes, cancer, immunodeficiency, HIV, transplant, chronic renal or hepatic diseases, cognitive or neurological disorders, hemoglobinopathies, and pregnancy.
Predictors of Clinical Outcomes in Children (Multivariable Logistic Regression)
| All Patients | Admitted Patients | |||
|---|---|---|---|---|
|
| ||||
| Hospital Admission | Antibiotic Prescription | Length of Stay >2 days | Oxygen Requirement | |
|
| ||||
| Weight Status | ||||
| Normal-Weight | Ref | Ref | Ref | Ref |
| Overweight | 0.7 (0.4-1.3) | 0.7 (0.5-1.2) | 1.5 (0.4-5.1) | 0.5 (0.2-1.7) |
| Obese | 1.2 (0.7-2.0) | 0.8 (0.6-1.3) | 0.7 (0.3-1.9) | 1.3 (0.5-3.3) |
|
| ||||
| Age | ||||
| 2-4 years | Ref | Ref | Ref | Ref |
| 5-9 years | 0.7 (0.4-1.1) | 0.8 (0.3-2.4) | 0.7 (0.2-1.8) | |
| 10-17 years | 0.9 (0.5-1.4) | 0.8 (0.2-2.7) | ||
| 18-21 years | ||||
|
| ||||
| Gender | ||||
| Female | Ref | Ref | Ref | Ref |
| Male | 1.0 (0.6-1.5) | 0.5 (0.2-1.2) | 0.5 (0.2-1.2) | |
|
| ||||
| Race | ||||
| Non-Hispanic White | Ref | Ref | Ref | Ref |
| Black or African American | 1.0 (0.7-1.5) | 1.1 (0.4-3.1) | 1.0 (0.4-2.7) | |
| Hispanic/Other/Unknown | 0.5 (0.3-1.1) | 1.0 (0.6-1.8) | 2.3 (0.5-9.8) | 0.8 (0.2-3.5) |
|
| ||||
| Insurance | ||||
| Public/None/Unknown | Ref | Ref | Ref | Ref |
| Any Private | 1.3 (0.8-2.0) | 1.0 (0.4-2.6) | 0.5 (0.2-1.2) | |
|
| ||||
| Year | ||||
| 2010-2011 | Ref | Ref | Ref | Ref |
| 2011-2012 | 0.8 (0.2-2.8) | 0.8 (0.2-2.5) | ||
| 2012-2013 | 1.4 (0.4-4.7) | 0.8 (0.2-2.8) | ||
| 2013-2014 | 0.2 (0.2-1.3) | 0.1 (0.01-2.2) | 0.4 (0.1-3.2) | |
|
| ||||
| Vaccination | ||||
| No or incomplete vaccination | Ref | Ref | Ref | Ref |
| Full vaccination | 1.2 (0.7-2.1) | 1.1 (0.7-1.7) | 0.5 (0.2-1.3) | 1.1 (0.4-2.9) |
|
| ||||
| High-Risk Condition | ||||
| None | Ref | Ref | Ref | Ref |
| Asthma | 0.9 (0.6-1.3) | 1.0 (0.4-2.9) | ||
| Other | ||||
Bold confidence intervals indicate significance at the 5% level
Predictors of Clinical Outcomes in Adults (Multivariable Logistic Regression)
| All Patients | Admitted Patients | |||
|---|---|---|---|---|
|
| ||||
| Hospital Admission | Antibiotic Prescription | Length of Stay >2 days | Oxygen Requirement | |
|
| ||||
| Weight Status | ||||
| Normal Weight | Ref | Ref | Ref | Ref |
| Overweight | 1.0 (0.8-1.2) | 1.0 (0.7-1.3) | 0.9 (0.7-1.2) | |
| Class 1 Obesity | 1.0 (0.8-1.3) | 0.8 (0.6-1.2) | 1.0 (0.7-1.4) | |
| Class 2 Obesity | 0.9 (0.7-1.2) | 1.3 (0.9-2.0) | ||
| Class 3 Obesity | 0.9 (0.6-1.2) | 1.0 (0.8-1.3) | 0.9 (0.6-1.2) | |
|
| ||||
| Age | \ | |||
| 22–34 years | Ref | Ref | Ref | Ref |
| 35-59 years | 1.1 (0.9-1.4) | 1.3 (0.8-2.3) | ||
| >50 years | ||||
|
| ||||
| Gender | ||||
| Female | Ref | Ref | Ref | Ref |
| Male | 1.0 (0.9-1.2) | 1.1 (0.9-1.4) | 0.8 (0.7-1.1) | |
|
| ||||
| Race | ||||
| Non-Hispanic White | Ref | Ref | Ref | Ref |
| Black or African American | 0.9 (0.7-1.1) | 0.8 (0.7-1.1) | ||
| Hispanic/Other/Unknown | 0.7 (0.4-1.2) | 0.9 (0.6-1.3) | 0.7 (0.4-1.5) | 1.2 (0.6-2.5) |
|
| ||||
| Insurance | ||||
| Public/None/Unknown | Ref | Ref | Ref | Ref |
| Any Private | 1.0 (0.7-1.2) | 0.9 (0.7-1.2) | ||
|
| ||||
| Year | ||||
| 2010-2011 | Ref | Ref | Ref | Ref |
| 2011-2012 | 1.0 (0.7-1.2) | 1.0 (0.7-1.5) | 1.3 (0.9-2.0) | |
| 2012-2013 | 0.9 (0.7-1.1) | 1.0 (0.7-1.5) | 1.0 (0.7-1.4) | |
| 2013-2014 | 0.7 (0.4-1.1) | |||
|
| ||||
| Vaccination | ||||
| No or incomplete vaccination | Ref | Ref | Ref | Ref |
| Full vaccination | 1.0 (0.9-1.2) | 1.0 (0.8-1.2) | ||
|
| ||||
| High-Risk Condition | ||||
| None | Ref | Ref | Ref | Ref |
| Asthma | 1.0 (0.8-1.2) | 1.4 (0.9-2.2) | ||
| Other | 1.0 (0.8-1.2) | 1.4 (0.9-2.2) | ||
Bold confidence intervals indicate significance at the 5% level.